The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: Insights from the COMPASS Trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: Insights from the COMPASS Trial
Authors
Keywords
-
Journal
CIRCULATION
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-03-28
DOI
10.1161/circulationaha.120.046448
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rationale, Design, and Baseline Characteristics of THEMIS: Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study
- (2019) Deepak L. Bhatt et al. CLINICAL CARDIOLOGY
- The rise and fall of aspirin in the primary prevention of cardiovascular disease
- (2019) Inbar Raber et al. LANCET
- More CREDENCE for SGLT2 Inhibition
- (2019) Subodh Verma et al. CIRCULATION
- Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial
- (2019) Sonia S. Anand et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Multiple Enrichment Criteria With Ischemic and Bleeding Risks Among COMPASS-Eligible Patients
- (2019) Arthur Darmon et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A LEADER in the management of type 2 diabetes and cardiorenal disease
- (2019) Subodh Verma et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
- (2019) Deepak L Bhatt et al. LANCET
- Is There Really a Benefit to Net Clinical Benefit in Testing Antithrombotics?
- (2018) Philippe Gabriel Steg et al. CIRCULATION
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Stuart J Connolly et al. LANCET
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Sonia S Anand et al. LANCET
- Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients with Diabetes Mellitus (From the SAVOR-TIMI 53 Trial)
- (2018) J. Antonio Gutierrez et al. AMERICAN JOURNAL OF CARDIOLOGY
- Will COMPASS Point to a New Direction in Thrombotic Risk Reduction in Patients With Stable Cardiovascular Disease?
- (2018) William E. Boden et al. CIRCULATION
- Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Can We DECLARE a Victory against Cardio-Renal Disease in Diabetes?
- (2018) Kim A. Connelly et al. Cell Metabolism
- Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke
- (2018) Subodh Verma et al. CIRCULATION
- The perils of polyvascular disease in type 2 diabetes
- (2018) Subodh Verma et al. Lancet Diabetes & Endocrinology
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
- (2016) Marc P. Bonaca et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51
- (2013) C. Michael Gibson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antiplatelet Therapy Following Myocardial Infarction in Patients With Diabetes
- (2012) Deepak L. Bhatt JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search